Characterization of three inhibitors of endothelial nitric oxide synthase in vitro and in vivo

British Journal of Pharmacology

Volumn 101, Issue 3, 1990, Pages 746-752

  Rees, D D ^a   Palmer, R M J ^a   Schulz, R ^a   Hodson, H F ^a   Moncada, S ^a  

^a WELLCOME RESEARCH LABORATORIES   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; ARGININE; BRADYKININ; CYCLIC GMP; INDOMETACIN; METHYLARGININE; N5 (1 IMINOETHYL)ORNITHINE; NITRIC OXIDE; NITROARGININE METHYL ESTER; PHENYLEPHRINE; RADIOISOTOPE; SYNTHETASE; UNCLASSIFIED DRUG;

ANIMAL CELL; AORTA; ARTICLE; BLOOD PRESSURE; BLOOD VESSEL TONE; CONCENTRATION RESPONSE; ENZYME INHIBITION; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; STEREOSPECIFICITY; SWINE; VASCULAR ENDOTHELIUM;

EID: 0025011716     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1476-5381.1990.tb14151.x     Document Type: Article

References (36)

1. AISAKA, K., GROSS, S.S., GRIFFITH, O.W. & LEVI, R. (1989a). N G ‐methylarginine, an inhibitor of endothelium‐derived nitric oxide synthesis, is a potent pressor agent in the guinea‐pig: does nitric oxide regulate blood pressure in vivo? Biochem. Biophys. Res. Commun., 160, 881–886.
2. AISAKA, K., GROSS, S.S., GRIFFITH, O.W. & LEVI, R. (1989b). l‐arginine availability determines the duration of acetylcholine‐induced systemic vasodilation in vivo. Biochem. Biophys. Res. Commun., 163, 710–717.
3. AMEZCUA, J.L., DUSTING, G.J., PALMER, R.M.J. & MONCADA, S. (1988). Acetylcholine induces vasodilatation in the rabbit isolated heart through the release of nitric oxide, the endogenous nitrovasodilator. Br. J. Pharmacol., 95, 830–834.
4. AMEZCUA, J.L., PALMER, R.M.J., de SOUZA, B.M. & MONCADA, S. (1989). Nitric oxide synthesized from l‐arginine regulates vascular tone in the coronary circulation of the rabbit. Br. J. Pharmacol., 97, 1119–1124.
5. DAWSON, R.M.C., ELLIOTT, D.C., ELLIOTT, W.H. & JONES, K.M. (1986). Data for Biochemical Research. pp. 404–405. Oxford: Clarendon.
6. FURCHGOTT, R.F. (1990). Endothelium‐derived relaxing factor: some old and new findings. In Nitric Oxide from l‐Arginine: a Bioregulatory System ed. Moncada, S. & Higgs, E.A. pp. 5–17. Amsterdam: Elsevier.
7. GARTHWAITE, J., GARTHWAITE, G., PALMER, R.M.J. & MONCADA, S. (1989). NMDA receptor activation induces nitric oxide synthesis from arginine in rat brain slices. Eur. J. Pharmacol., 172, 413–416.
8. GIBSON, A., SHOKOUFEH, M., HOBBS, A.J. & MOORE, P.K. (1990). l‐N G ‐monomethylarginine and l‐N G ‐nitroarginine inhibit non‐adrenergic, non‐cholinergic relaxation of the mouse anococcygeus muscle. Br. J. Pharmacol., 99, 602–606.
9. GILES, H., BOLOFO, M.L. & MARTIN, G.R. (1990). Agonist‐ and tissue‐dependence of susceptibility of endothelium‐dependent relaxations to l‐NAME. Br. J. Pharmacol., 100, 452P.
10. GILLESPIE, J.S., LIU, X. & MARTIN, W. (1989). The effects of l‐arginine and N G ‐monomethyl l‐arginine on the response of the rat anococcygeus muscle to NANC nerve stimulation. Br. J. Pharmacol., 98, 1080–1082.
11. IGNARRO, L.J., BUGA, G.M., WOOD, K.S., BYRNS, R.E. & CHAUDHURI, G. (1987). Endothelium‐derived relaxing factor produced and released from artery and vein is nitric oxide. Proc. Natl. Acad. Sci., U.S.A., 84, 9265–9269.
12. KELM, M. & SCHRADER, J. (1988). Nitric oxide release from the isolated guinea pig heart. Eur. J. Pharmacol., 155, 313–316.
13. KNOWLES, R.G., PALACIOS, M., PALMER, R.M.J. & MONCADA, S. (1989). Formation of nitric oxide from l‐arginine in the central nervous system: a transduction mechanism for stimulation of the soluble guanylate cyclase. Proc. Natl. Acad. Sci., U.S.A., 86, 5159–5162.
14. KNOWLES, R.G., PALACIOS, M., PALMER, R.M.J. & MONCADA, S. (1990). Kinetic characteristics of nitric oxide synthase from rat brain. Biochem. J., 269, 207–210.
15. KOBAYASHI, Y. & HATTORI, K. (1990). Nitroarginine inhibits endothelium‐derived relaxation. Jpn. J. Pharmacol., 52, 167–169.
16. LEVI, R., GROSS, S.S., LAMPARTER, B., FASEHUN, O.A., AISAKA, K., JAFFE, E.A., GRIFFITH, O.W. & STUEHR, D.J. (1990). Evidence that l‐arginine is the biosynthetic precursor of vascular and cardiac nitric oxide. In Nitric Oxide from l‐Arginine: a Bioregulatory System. ed. Moncada, S. & Higgs, E.A. pp. 35–45. Amsterdam: Elsevier.
17. McCALL, T. PALMER, R.M.J., BOUGHTON‐SMITH, N., WHITTLE, B.J.R. & MONCADA, S. (1990). The l‐arginine:nitric oxide pathway in neutrophils. In Nitric Oxide from l‐Arginine: a Bioregulatory System. ed. Moncada, S. & Higgs, E.A. pp. 257–265. Amsterdam: Elsevier.
18. MEYER, B., SCHMIDT, K., HUMBERT, R. & BOHME, E. (1989). Biosynthesis of endothelium‐derived relaxing factor, a cytosolic enzyme in porcine aortic endothelial cells Ca 2+ ‐dependently converts l‐arginine into an activator of guanylate cyclase. Biochem. Biophys. Res. Commun., 164, 678–685.
19. MOORE, P.K., AL‐SWAYEH, O.A., CHONG, N.W.S., EVANS, R.A. & GIBSON, A. (1990). l‐N G ‐nitro arginine (l‐NOARG) a novel, l‐arginine‐reversible inhibitor of endothelium‐dependent vasodilatation in vitro. Br. J. Pharmacol., 99, 408–412.
20. MÜLSCH, A., BASSENGE, E. & BUSSE, R. (1989). Nitric oxide synthesis in endothelial cytosol: Evidence for a calcium‐dependent and a calcium‐independent mechanism. Naunyn-Schmiedebergs Arch. Pharmacol., 340, 767–770.
21. MÜLSCH, A. & BUSSE, R. (1990). N G ‐nitro‐l‐arginine (N 5 ‐[imino(nitro amino)methyl]‐l‐ornithine) impairs endothelium‐dependent dilations by inhibiting cytosolic nitric oxide synthesis from l‐arginine. Naunyn-Schmiedebergs Arch. Pharmacol., 341, 143–147.
22. PALACIOS, M., KNOWLES, R.G., PALMER, R.M.J. & MONCADA, S. (1989). Nitric oxide from l‐arginine stimulates the soluble guanylate cyclase in adrenal glands. Biochem. Biophys. Res. Commun., 165, 802–809.
23. PALMER, R.M.J. & MONCADA, S. (1989). A novel citrulline‐forming enzyme implicated in the formation of nitric oxide by vascular endothelial cells. Biochem. Biophys. Res. Commun., 158, 348–352.
24. PALMER, R.M.J., FERRIGE, A.G. & MONCADA, S. (1987). Nitric oxide release accounts for the biological activity of endothelium‐derived relaxing factor. Nature, 327, 524–526.
25. PALMER, R.M.J., ASHTON, D.S. & MONCADA, S. (1988a). Vascular endothelial cells synthesize nitric oxide from l‐arginine. Nature, 333, 664–666.
26. PALMER, R.M.J., REES, D.D., ASHTON, D.S. & MONCADA, S. (1988b). l‐arginine is the physiological precursor for the formation of nitric oxide in endothelium‐dependent relaxation. Biochem. Biophys. Res. Commun., 153, 1251–1256.
27. PATTHY, A., BAJUSZ, S. & PATTHY, L. (1977). Preparation and characterisation of N G ‐mono‐di‐ and trimethylated arginines. Acta. Biochim. Biophys. Acad. Sci. Hung., 12, 191–196.
28. RADOMSKI, M.W., PALMER, R.M.J. & MONCADA, S. (1987a). Comparative pharmacology of endothelium‐derived relaxing factor, nitric oxide and prostacyclin in platelets. Br. J. Pharmacol., 92, 181–187.
29. RADOMSKI, M.W., PALMER, R.M.J. & MONCADA, S. (1987b). The antiaggregating properties of vascular endothelium: interactions between prostacyclin and nitric oxide. Br. J. Pharmacol., 92, 639–646.
30. RADOMSKI, M.W., PALMER, R.M.J. & MONCADA, S. (1990). Characterisation of the l‐arginine:nitric oxide pathway in human platelets. Br. J. Pharmacol. (in press).
31. REES, D.D., PALMER, R.M.J., HODSON, H.F. & MONCADA, S. (1989a). A specific inhibitor of nitric oxide formation from l‐arginine attenuates endothelium‐dependent relaxation. Br. J. Pharmacol., 96, 418–424.
32. REES, D.D., PALMER, R.M.J. & MONCADA, S. (1989b). Role of endothelium‐derived nitric oxide in the regulation of blood pressure. Proc. Natl. Acad. Sci. U.S.A., 86, 3375–3378.
33. SAKUMA, I., STUEHR, D.J., GROSS, S.S., NATHAN, C. & LEVI, R. (1988). Identification of arginine as a precursor of endothelium‐derived relaxing factor (EDRF). Proc. Natl. Acad. Sci., U.S.A., 85, 8664–8667.
34. SCANNELL, J.P., AX, H.A., PRUESS, D.L., WILLIAMS, T., DEMNY, T.C. & STEMPEL, A. (1972). Antimetabolites produced by microorganisms. VI. L‐N‐(1‐iminoethyl) ornithine. J. Antibiot., 25, 179–184.
35. VALLANCE, P., COLLIER, J. & MONCADA, S. (1989a). Effects of endothelium‐derived nitric oxide on peripheral arteriolar tone in man. Lancet, ii, 997–1000.
36. VALLANCE, P., COLLIER, J. & MONCADA, S. (1989b). Nitric oxide synthesised from l‐arginine mediates endothelium‐dependent dilatation in human veins. Cardiovasc. Res., 23, 1053–1057.